BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma
Clinical trial NCT00287495 · TERMINATED
Trial details
- NCT number
- NCT00287495
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-02
- Primary completion
- 2012-09-21
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.